These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 21914351)

  • 21. [Updates on antigen retrieval techniques for immunohistochemistry].
    Shi SR; Shi Y; Taylor CR
    Zhonghua Bing Li Xue Za Zhi; 2007 Jan; 36(1):7-10. PubMed ID: 17374230
    [No Abstract]   [Full Text] [Related]  

  • 22. Study of interlaboratory reliability and reproducibility of estrogen and progesterone receptor assays in Europe. Documentation of poor reliability and identification of insufficient microwave antigen retrieval time as a major contributory element of unreliable assays.
    Rhodes A; Jasani B; Balaton AJ; Barnes DM; Anderson E; Bobrow LG; Miller KD
    Am J Clin Pathol; 2001 Jan; 115(1):44-58. PubMed ID: 11190807
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Topoisomerase II alpha expression and the Ki-67 labeling index correlate with prognostic factors in estrogen receptor-positive and human epidermal growth factor type-2-negative breast cancer.
    Tokiniwa H; Horiguchi J; Takata D; Kikuchi M; Rokutanda N; Nagaoka R; Sato A; Odawara H; Tozuka K; Oyama T; Takeyoshi I
    Breast Cancer; 2012 Oct; 19(4):309-14. PubMed ID: 21725655
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunohistochemical evaluation of estrogen and progesterone receptors in paraffin-embedded, formalin-fixed endometrial tissues: comparison with enzyme immunoassay and immunohistochemical analysis of frozen tissue.
    Ravn V; Havsteen H; Thorpe SM
    Mod Pathol; 1998 Aug; 11(8):709-15. PubMed ID: 9720497
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Detection and assessment of Ki-67 in breast cancer].
    Shui RH; Yang WT
    Zhonghua Bing Li Xue Za Zhi; 2013 Jun; 42(6):420-3. PubMed ID: 24060083
    [No Abstract]   [Full Text] [Related]  

  • 26. [Immunohistochemical evaluation of estrogen and progesterone receptors on paraffin sections of breast carcinomas. Practical thoughts based on the study of 368 cases].
    Balaton AJ; Baviera EE; Galet B; Vaury P; Vuong PN
    Arch Anat Cytol Pathol; 1995; 43(1-2):93-100. PubMed ID: 7794034
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Estimation of hormone receptor status in fine-needle aspirates and paraffin-embedded sections from breast cancer using the novel rabbit monoclonal antibodies SP1 and SP2.
    Cano G; Milanezi F; Leitão D; Ricardo S; Brito MJ; Schmitt FC
    Diagn Cytopathol; 2003 Oct; 29(4):207-11. PubMed ID: 14506673
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The importance of estrogen and progesterone receptor in primary breast cancer.
    Clark GM; McGuire WL; Hubay CA; Pearson OH; Carter AC
    Prog Clin Biol Res; 1983; 132E():183-90. PubMed ID: 6647468
    [No Abstract]   [Full Text] [Related]  

  • 29. Estrogen and progesterone receptors in breast cancer.
    Yip CH; Rhodes A
    Future Oncol; 2014 Nov; 10(14):2293-301. PubMed ID: 25471040
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neoadjuvant chemotherapy-induced changes in immunohistochemical expression of estrogen receptor, progesterone receptor, HER2, and Ki-67 in patients with breast cancer.
    Avci N; Deligonul A; Tolunay S; Cubukcu E; Fatih Olmez O; Ulas A; Hartavi M; Kurt E; Evrensel T
    J BUON; 2015; 20(1):45-9. PubMed ID: 25778295
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A validation study of quantum dot multispectral imaging to evaluate hormone receptor status in ductal carcinoma in situ of the breast.
    Yu J; Monaco SE; Onisko A; Bhargava R; Dabbs DJ; Cieply KM; Fine JL
    Hum Pathol; 2013 Mar; 44(3):394-401. PubMed ID: 23039940
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Determination of estrogen and progesterone receptors in cancer of the breast. Frequency of presentation and prognostic significance].
    Expósito J; Olea N; Ruiz de Almodovar JM; Pedraza V
    Rev Esp Oncol; 1985; 32(3):471-85. PubMed ID: 3870538
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of two score systems in Bcl-2 and Bax protein expression in invasive ductal carcinoma of breast and relation with oestrogen and progestrone receptors.
    Ayatollahi H; Ghaffarzadegan K; Sharifi N; Farahmand MJ; Jarafian AH
    Breast J; 2009; 15(3):310-2. PubMed ID: 19645793
    [No Abstract]   [Full Text] [Related]  

  • 34. Pure and mixed hormone receptor positive breast tumors: are they different from therapeutic point of view?
    Altundag K; Altundag O; Gunduz E; Silay YS; Boruban C
    Med Hypotheses; 2005; 65(1):194. PubMed ID: 15893141
    [No Abstract]   [Full Text] [Related]  

  • 35. A magic bullet for breast cancer.
    Hubbard D
    J Nucl Med; 1986 Feb; 27(2):305. PubMed ID: 3712047
    [No Abstract]   [Full Text] [Related]  

  • 36. Relationship of cytoplasmic and nuclear estrogen receptors and progesterone receptors in human breast cancer.
    Romić-Stojković R; Gamulin S
    Cancer Res; 1980 Dec; 40(12):4821-5. PubMed ID: 7438115
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Progesterone, glucocorticoid, but not estrogen receptor mRNA is altered in breast cancer stroma.
    Smith RA; Lea RA; Weinstein SR; Griffiths LR
    Cancer Lett; 2007 Sep; 255(1):77-84. PubMed ID: 17512111
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Apocrine carcinoma as triple-negative breast cancer: novel definition of apocrine-type carcinoma as estrogen/progesterone receptor-negative and androgen receptor-positive invasive ductal carcinoma.
    Tsutsumi Y
    Jpn J Clin Oncol; 2012 May; 42(5):375-86. PubMed ID: 22450930
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hormone receptors in the management of breast cancer.
    Osborne CK
    Tex Med; 1984 Nov; 80(11):30-2. PubMed ID: 6515569
    [No Abstract]   [Full Text] [Related]  

  • 40. [New potential of estrogen and progesterone receptor assay in cytological smears sampled from breast cancer patients].
    Ellinidi VN; Anikeeva NV; Goncharova OA; Novik VI
    Vopr Onkol; 2004; 50(3):355-6. PubMed ID: 15318713
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.